Jean Franchi Net Worth & Insider Trades

Jean Franchi - Chief Financial Officer, Replimune Group, Inc

As of May 18, 2022

What is Jean Franchi's Net Worth?

The current estimated net worth of Replimune Group, Inc's Chief Financial Officer, Jean Franchi, is estimated to be about $3.4M . Jean Franchi owns about 95,099 units of Replimune Group, Inc common stock. In the last 3 years at Replimune Group, Inc, Jean Franchi has sold an estimated value of $1.8M worth.

What is Jean Franchi's Past Insider Trading?

Jean Franchi's largest purchase order was 25,000 units , worth over $352K on December 16, 2020. Jean Franchi's largest sale order was 25,000 units , worth over $1.09M on December 16, 2020. In total, Jean Franchi has made about 7 transactions over 3 years of their time at Replimune Group, Inc. Jean Franchi usually trades in April, with the busiest year in 2022, 2021 and 2020. The most recent transaction was a sale order of 3,436 units , worth over $50.13K on May 18, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jean Franchi's' Mailing Address?

  • Mailing address is C/o Dimension Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139 MA

Replimune Group, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1737953/000110465921094885/tm2122609-1_def14a.htm

What are Replimune Group, Inc's Past Insider Trades?

Replimune Group, Inc's most recent insider trade came on May 18, 2022 by Colin Love who sold 6,324 units worth $92.27K . In the last 4 years, insiders at Replimune Group, Inc have sold an estimated value of $79.44M and bought an estimated value of $35.46M worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are Colin Love, Chief Operating Officer,  Omega Fund Iv GP Lp,  and Omega Fund Iv GP Manager Ltd .

Replimune Group, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1